OrbiMed New Horizons Fund, L.P. — Form D/A
OrbiMed New Horizons Fund, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2021-04-14. $47.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-04-14
- Form: D/A
- Accession: 0000902664-21-002319
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $47.3M
- Investors: 47
- Date of first sale: 2020-04-01
- Security types: equity, fund interests
- SEC file number: 021-364898
Issuer
- Name: OrbiMed New Horizons Fund, L.P.
- CIK: 0001808097
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: C/O ORBIMED NEW HORIZONS GP LLC, NEW YORK, NY, 10022
- Phone: (212) 739-6400
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Jonathan T Silverstein | Executive Officer | New York, NY |
| - OrbiMed Advisors LLC | Executive Officer | New York, NY |
| - OrbiMed Advisors LLC | Promoter | New York, NY |
| Geoffrey C Hsu | Executive Officer | New York, NY |
| W. Carter Neild | Executive Officer | NEW YORK, NY |
| Matthew S Rizzo | Executive Officer | New York, NY |
| Sven H Borho | Executive Officer | New York, NY |
| Peter A Thompson | Executive Officer | New York, NY |
| C. Scotland Stevens | Executive Officer | New York, NY |
| David P Bonita | Executive Officer | New York, NY |
| - OrbiMed New Horizons GP LLC | Executive Officer | New York, NY |
| Carl L Gordon | Executive Officer | Stamford, CT |
Other filings by this issuer (3)
More